Suboxone Tooth Decay Lawsuit
Choose Flint Cooper’s team of mass tort attorneys to listen to your unique story, and provide meaningful benefits for you and your family.
Schedule a Free Consultation
Schedule a Free Consultation
Suboxone Tooth Decay Lawsuit
At Flint Cooper, we are committed to upholding the rights of individuals who have been adversely affected by Suboxone, a drug that is prescribed to patients suffering from an opioid use disorder for the purpose of suppressing withdrawal symptoms. Indivior, the manufacturer of the drug, is accused of withholding information from both healthcare professionals and patients regarding the risk of severe dental problems caused by the sublingual film version of Suboxone, such as tooth decay, oral infections, cavities and tooth loss.
These allegations highlight a breach of trust in the dissemination of crucial health-related information, impacting individuals who have relied on Suboxone to address their opioid use disorders.
If you believe you may be entitled to compensation due to dental issues related to Suboxone use, we encourage you to schedule a free consultation with Flint Cooper at +1 618.288.4777 to discuss your legal options and potential recourse.
The fact that this harmful and defective product was knowingly peddled to a demographic already reeling from the opioid epidemic borders on criminal.
Trent B. Miracle
Mass Torts & Product Liability Attorney
$1,000,000,000+
Latest Suboxone Lawsuit Updates
November 2023: Fourteen new Suboxone lawsuits have been filed in federal courts against the manufacturer, Indivior. Eight of these lawsuits were filed in the Northern District of Ohio, which has the greatest number of pending Suboxone cases of any district. A petition has been filed with the Judicial Panel on Multidistrict Litigation seeking to have all federally filed Suboxone cases consolidated before a single judge in the Northern District of Ohio.
October 2023: Indivior agreed to pay $385 million to resolve Suboxone lawsuits filed by drug wholesalers, marking a crucial milestone in addressing legal repercussions.
September 2023: David Sorensen filed a Suboxone tooth decay lawsuit against Indivior, Reckitt Benckiser, and other defendants, citing permanent damage to his teeth and the need for substantial dental work as a result of using the drug.
August 2023: Indivior settled for $30 million with healthcare plans involved in a federal antitrust lawsuit, further highlighting the intricate legal landscape surrounding Suboxone.
April 2023: The Federal Trade Commission disbursed approximately $369,000 to consumers participating in Suboxone class-action lawsuits who missed the original deadline.
January 2022: The Food and Drug Administration publicly disclosed reports indicating that medications containing buprenorphine, including Suboxone, could lead to dental problems when dissolved in the mouth. This revelation prompted the FDA to mandate an updated warning in the drug’s prescribing information and patient medication guide, emphasizing the agency’s commitment to ensuring public safety and awareness.
Unmasking Suboxone Related Risks
A comprehensive study conducted in 2022 appears to confirm a link between Suboxone usage and dental injuries. The research focused on three distinct groups of individuals using different medications: sublingual buprenorphine, transdermal buprenorphine, and oral naltrexone. Notably, the group employing sublingual buprenorphine exhibited a heightened susceptibility to dental problems compared to the other groups.
Specific findings revealed a higher incidence of dental issues, such as cavities and tooth loss, in the sublingual buprenorphine group. The risk of encountering dental problems was 1.42 times greater than in those using transdermal buprenorphine and 1.67 times higher than in those utilizing oral naltrexone.
Researchers presume that the acidic nature of sublingual buprenorphine could be the driving force behind these dental complications. Individuals consuming this medication are instructed to allow it to dissolve under their tongue for a few minutes, potentially subjecting their teeth to prolonged acid exposure.
Flint Cooper attorneys discern from these findings that Suboxone sublingual films exhibit a notably acidic profile. The understanding that acidity contributes to tooth decay aligns with the dissolution of these films under the tongue, introducing acidity into the oral cavity and progressively weakening tooth enamel, the protective outer layer of your teeth. As enamel diminishes, the underlying dentin layer becomes more susceptible to decay.
Do I Qualify To File a Suboxone Lawsuit?
If you have experienced dental issues after being prescribed Suboxone, you may qualify to file a Suboxone tooth decay lawsuit, but only a licensed Suboxone attorney can determine whether or not you qualify.
Qualifications:
- You have been prescribed Suboxone for opioid addiction or pain management
- You must have used Suboxone for a minimum of six months before sustaining the dental injuries in question
- Eligibility is extended to individuals experiencing: cavities, tooth loss, oral infections, tooth fractures, tooth decay or tongue and gum injuries
- You must have or be able to obtain a documented history of routine dental care before Suboxone usage
How Flint Cooper Can Help
Our legal team is ready to advocate on your behalf and seek compensation for the hardships you have endured. Navigating the complexities of pharmaceutical litigation requires legal expertise, and Flint Cooper is well-equipped to guide you through the process. Your well-being is our priority, and we are dedicated to seeking justice for those impacted by the alleged negligence surrounding Suboxone. Flint Cooper operates on a contingency basis, meaning you will pay zero expenses unless a settlement is won on your behalf. To schedule a free consultation please call +1 618.288.4777
Practice Areas
Asbestos
Mass Torts
Personal Injury
